Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Abbott HbA1c Test FDA Cleared to Diagnose Diabetes

Jun 21, 2018
|
staff reporter

NEW YORK (360Dx) – Abbott said on Thursday that the US Food and Drug Administration has cleared the company's Afinion HbA1c Dx assay to help diagnose diabetes mellitus and assess a patient's risk of developing the disease.

The rapid point-of-care assay was cleared to run on Abbott's Afinion AS100 Analyzer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants Emergency Use Authorization for SML Genetree Molecular Coronavirus Test

  2. Chembio Nabs CE Mark for SARS-CoV-2 Tests, Inks Distribution Agreement with Luas Diagnostics

  3. Ortho Clinical Diagnostics COVID-19 Antigen Test Receives FDA EUA for High-Volume Testing

  4. Thermo Fisher Scientific Unit Phadia Gets FDA EUA for Coronavirus Antibody Test

  5. Siemens Healthineers, Advaite Get FDA Emergency Use Authorizations for Coronavirus Antibody Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.